CDH
Charles D. Hyman’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $376K | Hold |
5,476
| – | – | 0.02% | 182 |
|
2024
Q1 | $401K | Sell |
5,476
-100
| -2% | -$7.32K | 0.02% | 184 |
|
2023
Q4 | $452K | Hold |
5,576
| – | – | 0.03% | 171 |
|
2023
Q3 | $418K | Sell |
5,576
-325
| -6% | -$24.4K | 0.03% | 170 |
|
2023
Q2 | $455K | Hold |
5,901
| – | – | 0.03% | 171 |
|
2023
Q1 | $490K | Hold |
5,901
| – | – | 0.03% | 162 |
|
2022
Q4 | $507K | Hold |
5,901
| – | – | 0.03% | 154 |
|
2022
Q3 | $364K | Hold |
5,901
| – | – | 0.03% | 171 |
|
2022
Q2 | $365K | Buy |
5,901
+1,500
| +34% | +$92.8K | 0.03% | 174 |
|
2022
Q1 | $262K | Hold |
4,401
| – | – | 0.02% | 217 |
|
2021
Q4 | $320K | Hold |
4,401
| – | – | 0.02% | 203 |
|
2021
Q3 | $307K | Hold |
4,401
| – | – | 0.02% | 196 |
|
2021
Q2 | $303K | Hold |
4,401
| – | – | 0.02% | 202 |
|
2021
Q1 | $284K | Hold |
4,401
| – | – | 0.02% | 203 |
|
2020
Q4 | $256K | Sell |
4,401
-1,000
| -19% | -$58.2K | 0.02% | 207 |
|
2020
Q3 | $341K | Sell |
5,401
-35
| -0.6% | -$2.21K | 0.03% | 170 |
|
2020
Q2 | $418K | Buy |
5,436
+35
| +0.6% | +$2.69K | 0.04% | 149 |
|
2020
Q1 | $404K | Sell |
5,401
-82
| -1% | -$6.13K | 0.05% | 127 |
|
2019
Q4 | $356K | Buy |
5,483
+1,019
| +23% | +$66.2K | 0.03% | 152 |
|
2019
Q3 | $283K | Hold |
4,464
| – | – | 0.03% | 158 |
|
2019
Q2 | $302K | Sell |
4,464
-150
| -3% | -$10.1K | 0.03% | 155 |
|
2019
Q1 | $300K | Buy |
4,614
+450
| +11% | +$29.3K | 0.03% | 154 |
|
2018
Q4 | $260K | Hold |
4,164
| – | – | 0.03% | 144 |
|
2018
Q3 | $322K | Sell |
4,164
-74
| -2% | -$5.72K | 0.03% | 141 |
|
2018
Q2 | $300K | Buy |
4,238
+74
| +2% | +$5.24K | 0.03% | 142 |
|
2018
Q1 | $314K | Hold |
4,164
| – | – | 0.04% | 136 |
|
2017
Q4 | $298K | Buy |
4,164
+1,100
| +36% | +$78.7K | 0.03% | 133 |
|
2017
Q3 | $248K | Hold |
3,064
| – | – | 0.03% | 132 |
|
2017
Q2 | $217K | Sell |
3,064
-500
| -14% | -$35.4K | 0.03% | 137 |
|
2017
Q1 | $242K | Buy |
+3,564
| New | +$242K | 0.03% | 126 |
|